keyword
MENU ▼
Read by QxMD icon Read
search

Essure

keyword
https://www.readbyqxmd.com/read/29046622/essure%C3%A2-present-controversies-and-5%C3%A2-years-learned-lessons-a-retrospective-study-with-short-and-long-term-follow-up
#1
Sara Câmara, Filipa de Castro Coelho, Cláudia Freitas, Lilia Remesso
BACKGROUND: The risk-benefit of contraception with Essure® is being readdressed due to an increase of reports of adverse effects with this device. Our aim was to proceed to an internal quality evaluation and to identify opportunities for protocol improvement. We proceeded to a one-center, retrospective consecutive case series of women admitted for Essure® placement, from 1 January 2012 until 31 December 2016 (5 years). RESULTS: In a total of 274 women, technical difficulties were mainly unilateral, with no acute or short-term severe complications...
2017: Gynecological Surgery
https://www.readbyqxmd.com/read/29046105/safety-and-patients-satisfaction-after-hysteroscopic-sterilisation
#2
María Nieves Cabezas-Palacios, Antonio Jiménez-Caraballo, Sara Tato-Varela, Alicia Sánchez-Sánchez, Carlos Romero-Díaz, Antonio Carrasco-Gallego, Ignacio Zapardiel-Gutiérrez
The aim of this study was to understand the potential complications of the Essure(®) device as well as the factors influencing its onset and patient satisfaction. We present a 9-year descriptive prospective study that included 1068 patients. The device was placed in 1056 of them (98.8%); 894 had no pain or mild pain during the insertion and only 12 patients experienced pain greater than menstrual pain. The proportion of patients without pain was greater in the group that took NSAIDs or NSAIDs and BZD and the unmedicated group had the highest rate of severe pain (p = ...
October 19, 2017: Journal of Obstetrics and Gynaecology: the Journal of the Institute of Obstetrics and Gynaecology
https://www.readbyqxmd.com/read/28987213/update-on-the-essure-system-for-permanent-birth-control
#3
Heidi Collins Fantasia
In 2002, the U.S. Food and Drug Administration approved the Essure system for permanent birth control. Implantation with this device offers a minimally invasive option for permanent female contraception that is placed during a brief office visit. Unlike laparoscopic tubal sterilization, the Essure procedure requires no hospitalization or general anesthesia, resulting in minimal recovery time. After a decade of stability in the report of adverse effects, the U.S. Food and Drug Administration noted a sharp increase in patient-reported adverse events, including chronic pelvic pain, irregular bleeding, allergic reactions, and autoimmune-like reactions...
October 2017: Nursing for Women's Health
https://www.readbyqxmd.com/read/28939482/review-of-sterilization-techniques-and-clinical-updates
#4
REVIEW
Nisse V Clark, Scott P Endicott, Elisa M Jorgensen, Hye-Chun Hur, Ernest G Lockrow, Mary E Kern, Candice E Jones-Cox, Susan G Dunlow, Jon I Einarsson, Sarah L Cohen
Sterilization is the most common form of contraception used worldwide and is highly effective in preventing unintended pregnancy. Several sterilization methods exist, each with unique advantages and disadvantages that influence the preferred approach for an individual patient. Salpingectomy for sterilization has popularized in recent years with mounting evidence suggesting a protective effect against ovarian cancers that originate from the fallopian tube. At the same time, Essure® hysteroscopic sterilization has come under scrutiny due to increasing reports of adverse effects that may be related to the device...
September 19, 2017: Journal of Minimally Invasive Gynecology
https://www.readbyqxmd.com/read/28873982/-forgotten-chapters-in-the-history-of-transcervical-sterilization-carl-clauberg-and-hans-joachim-lindemann
#5
Sabine Hildebrandt, Susan Benedict, Erin Miller, Michael Gaffney, Michael A Grodin
Transcervical sterilization is a non-surgical method of permanent female sterilization that is widely used and critically discussed. A review of the historiography of the method reveals that instances of its coercive use are not included in the historical account. This study offers a reexamination of the work of Carl Clauberg and Hans-Joachim Lindemann, to more deeply contextualize within the framework of current usage the coercive use of transcervical sterilization during the Third Reich and in postwar Germany...
July 1, 2017: Journal of the History of Medicine and Allied Sciences
https://www.readbyqxmd.com/read/28844663/radiological-assessment-of-the-placement-of-essure-%C3%A2-in-order-to-reduce-hysterosalpingography-pelvic-x-ray-versus-combined-pelvic-x-ray-and-ultrasound
#6
C Petit, T Vernet, P Verpillat, C Rubod, M Cosson, G Giraudet
OBJECTIVE: Three months after hysteroscopic sterilisation with Essure(®), a confirmation test is required to evaluate the correct location of the inserts. The test may be conducted using a pelvic ultrasound (2D or 3D) or an abdominal X-ray. Should the location not look satisfactory on these tests, a follow-up hysterosalpingography (HSG) would be required. The objective of our study is to assess whether the Essure(®) 3-month confirmation test using a single X-ray or a combination of X-ray and ultrasound could reduce the use of HSG...
October 2017: Journal of gynecology obstetrics and human reproduction
https://www.readbyqxmd.com/read/28780019/-surgical-technique-for-essure-%C3%A2-device-ablation-with-video
#7
N Oufkir, A Pinard, V Villefranque
No abstract text is available yet for this article.
August 2, 2017: Gynecologie, Obstetrique, Fertilite & Senologie
https://www.readbyqxmd.com/read/28676451/reproducibility-of-the-interpretation-of-coronal-3d-ultrasound-view-of-the-uterus-to-evaluate-the-position-of-essure-%C3%A2-3-months-after-hysteroscopic-procedure
#8
P Capmas, I Letendre, J-M Levaillant, F Fuchs, P Panel, G Chambon, V Villefranque, Y Levy-Zauberman, H Fernandez
OBJECTIVE: Three-dimensional sonography is a good alternative method to assess the position of microinserts. Adequate position after three months allows for the interruption of other contraception. Objective is to evaluate inter-observer reproducibility of the interpretation of coronal transvaginal 3D ultrasound view of the uterus to evaluate the position of Essure(®). STUDY DESIGN: Inter-observer reproducibility study. Fifty women underwent successful bilateral placement of microinserts (Essure(®)) by hysteroscopy in the Department of Gynaecology of a teaching hospital and were included in the study...
July 1, 2017: Journal of gynecology obstetrics and human reproduction
https://www.readbyqxmd.com/read/28599885/essure-removal-for-the-treatment-of-device-attributed-symptoms-an-expanded-case-series-and-follow-up-survey
#9
Nisse V Clark, Doortje Rademaker, Avery A Mushinski, Mobolaji O Ajao, Sarah L Cohen, Jon I Einarsson
STUDY OBJECTIVE: To evaluate perioperative outcomes and symptom resolution in women undergoing removal of the Essure device for device-attributed symptoms. DESIGN: Retrospective case series and follow-up patient survey (Canadian Task Force classification III). SETTING: Large academic medical center. PATIENTS: Fifty-two women who underwent laparoscopic or hysteroscopic Essure removal between 2012 and 2016. INTERVENTIONS: Women underwent one of four procedures: laparoscopic hysterectomy (LH) and bilateral salpingectomy (BS), laparoscopic BS and cornuectomy, laparoscopic Essure removal and BS, or hysteroscopic Essure removal and laparoscopic BS...
June 6, 2017: Journal of Minimally Invasive Gynecology
https://www.readbyqxmd.com/read/28579408/pregnancy-outcome-of-in%C3%A2-vitro-fertilization-after-essure-and-laparoscopic-management-of-hydrosalpinx-a-systematic-review-and-meta-analysis
#10
REVIEW
Bin Xu, Qiong Zhang, Jing Zhao, Yonggang Wang, Dabao Xu, Yanping Li
OBJECTIVE: To assess and compare pregnancy outcomes in hydrosalpinx (HX) patients treated by Essure, laparoscopic salpingectomy, and proximal tubal occlusion (LPTO) before IVF. DESIGN: Systematic review and meta-analysis. SETTING: University-affiliated teaching hospital. PATIENT(S): Women undergoing Essure, laparoscopic salpingectomy, and LPTO for HX before IVF. INTERVENTION(S): The overall combined risk estimates were calculated by means of fixed- or random-effects models...
July 2017: Fertility and Sterility
https://www.readbyqxmd.com/read/28537948/current-techniques-and-outcomes-in-hysteroscopic-sterilization-current-evidence-considerations-and-complications-with-hysteroscopic-sterilization-micro-inserts
#11
James Casey, Laura Cedo-Cintron, Jessica Pearce, Amanda Yunker
PURPOSE OF REVIEW: To describe the current data regarding effectiveness, complications, postoperative evaluation, and surgical interventions associated with Essure hysteroscopic sterilization. RECENT FINDINGS: Hysteroscopic sterilization is a commonly performed procedure that is offered as a well tolerated, effective, outpatient method of permanent sterilization. Over the past several years, concerns have been raised regarding correct placement and postoperative complications...
August 2017: Current Opinion in Obstetrics & Gynecology
https://www.readbyqxmd.com/read/28534016/analysis-of-surgeries-performed-after-hysteroscopic-sterilization-as-tabulated-from-3-803-essure-patient-experiences
#12
E Scott Sills, Xiang Li, Samuel H Wood, Christopher A Jones
OBJECTIVE: Although previous research has suggested that risk for reoperation among hysteroscopic sterilization (HS) patients is more than ten times higher than for patients undergoing standard laparoscopic tubal ligation, little has been reported about these subsequent procedures. METHODS: This descriptive cohort study used a confidential online questionnaire to gather data from women (n=3,803) who volunteered information on HS followed by device removal surgery performed due to new symptoms developing after Essure placement...
May 2017: Obstetrics & Gynecology Science
https://www.readbyqxmd.com/read/28472830/definitive-contraception-trends-in-a-ten-year-interval
#13
Cecília Maria Ventuzelo Marques, Magda Maria do Vale Pinto Magalhães, Maria João Leal da Silva Carvalho, Giselda Marisa Costa Carvalho, Francisco Augusto Falcão Santos Fonseca, Isabel Torgal
Objective To evaluate the trends in definitive contraception in a ten-year interval comprising the years 2002 and 2012. Method Retrospective analysis of the tubal sterilization performed in our service in 2002 and 2012, analyzing the demographic characteristics, personal history, previous contraceptive method, definite contraception technique, effectiveness and complications. Results Definitive contraception was performed in 112 women in 2002 (group 1) and in 60 women in 2012 (group 2). The groups were homogeneous regarding age, parity, educational level and personal history...
July 2017: Revista Brasileira de Ginecologia e Obstetrícia
https://www.readbyqxmd.com/read/28464415/safety-and-effectiveness-of-female-tubal-sterilisation-by-hysteroscopy-laparoscopy-or-laparotomy-a-register-based-study
#14
E Jokinen, A Heino, T Karipohja, M Gissler, R Hurskainen
OBJECTIVE: To determine the safety and effectiveness of female sterilisation in the Finnish population. DESIGN: A national register-based study using record linkage. SETTING: National data from Finland. SAMPLE: A total of 16 272 female sterilisations performed in 2009-2014. METHODS: The Register of Sterilisations was linked with the Hospital Discharge Register, Termination of Pregnancy Register, and the Medical Birth Register in order to investigate the occurrence of re-sterilisations, other surgical operations, and unwanted pregnancies after sterilisation, per method...
May 2, 2017: BJOG: An International Journal of Obstetrics and Gynaecology
https://www.readbyqxmd.com/read/28461235/-how-i-do%C3%A2-laparoscopic-removal-of-essure-%C3%A2-device
#15
G Chene, P Vidican, C Azzi, K Lebail Carval, P Chabert, E Beaufils, G Mellier, G Lamblin
No abstract text is available yet for this article.
May 2017: Gynecologie, Obstetrique, Fertilite & Senologie
https://www.readbyqxmd.com/read/28390945/intraoperative-factors-that-predict-the-successful-placement-of-essure-microinserts
#16
Chloé J Arthuis, Emmanuel G Simon, Thomas Hébert, Henri Marret
STUDY OBJECTIVE: To determine whether the number of coils visualized in the uterotubal junction at the end of hysteroscopic microinsert placement predicts successful tubal occlusion. DESIGN: Cohort retrospective study (Canadian Task Force classification II-2). SETTING: Department of obstetrics and gynecology in a teaching hospital. PATIENTS: One hundred fifty-three women underwent tubal microinsert placement for permanent birth control from 2010 through 2014...
April 5, 2017: Journal of Minimally Invasive Gynecology
https://www.readbyqxmd.com/read/28385588/outcomes-of-elective-outpatient-hysteroscopic-sterilization-in-undocumented-women-a-retrospective-analysis
#17
Patsy J McGuire, Jennifer Butler, Christina Gavito, Jeanelle Sheeder, Kristina Tocce
OBJECTIVE: To determine the feasibility of hysteroscopic sterilization in low-income and unauthorized immigrant women when financial barriers to care are removed. METHODS: Outpatient hysteroscopic sterilization for low-income women at an urban clinic was made possible by grant funding. All procedures were performed by obstetrician/gynecologist attending physicians or supervised trainees. Electronic records were reviewed for cases performed from June 2010 to December 11, 2013...
April 3, 2017: Women's Health Issues: Official Publication of the Jacobs Institute of Women's Health
https://www.readbyqxmd.com/read/28333802/hysteroscopic-sterilization-with-essure-summary-of-the-u-s-food-and-drug-administration-actions-and-policy-implications-for-postmarketing-surveillance
#18
Rachel Steward
No abstract text is available yet for this article.
April 2017: Obstetrics and Gynecology
https://www.readbyqxmd.com/read/28259704/-can-we-still-afford-to-put-essure-%C3%A2
#19
EDITORIAL
P Panel, P Baissas
No abstract text is available yet for this article.
March 2017: Gynecologie, Obstetrique, Fertilite & Senologie
https://www.readbyqxmd.com/read/28254503/medicolegal-review-essure-lawsuits-and-legal-strategies-adverse-to-gynecologists
#20
REVIEW
Amber M Klimczak, Russell R Snyder, Mostafa A Borahay, John Y Phelps
The minimally invasive Essure procedure for hysteroscopic sterilization is an ongoing target for litigation. Although efficacious, this device has been scrutinized by the US Food and Drug Administration (FDA) owing to alleged complications. Patients affected by these potential complications are filing lawsuits against Bayer, the manufacturer of Essure. Many of these lawsuits have been barred by preemption, a legal doctrine that limits what can be required of a product by state lawsuits once the FDA approves it; however, in the lawsuits that have been allowed to proceed, the manufacturer has used a legal strategy termed the "learned intermediary doctrine" in an effort to shift blame to the gynecologist to absolve itself of liability...
February 27, 2017: Journal of Minimally Invasive Gynecology
keyword
keyword
20219
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"